Last week, Johnson & Johnson reached a $300 million settlement for two class actions brought by Australian women affected by complications from vaginal mesh products.

The products are surgically implanted to correct urinary incontinence or prolapse.

However, women involved in the class action experienced a range of issues with vaginal mesh implants, including chronic pain, painful intercourse and incontinence.

The first of the Australian class actions against Johnson & Johnson was filed in 2012. Justice Katzmann ruled the company had not fully researched these products (which carried significant risks), was motivated by commercial factors and had failed to give doctors or patients adequate safety information.